nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—HRH1—atherosclerosis	0.348	1	CbGaD
Quetiapine—CYP3A7—Simvastatin—atherosclerosis	0.0263	0.0702	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0263	0.0702	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0257	0.0687	CbGbCtD
Quetiapine—CYP3A7—Lovastatin—atherosclerosis	0.0257	0.0687	CbGbCtD
Quetiapine—CYP3A5—Rosuvastatin—atherosclerosis	0.0212	0.0567	CbGbCtD
Quetiapine—CYP3A5—Simvastatin—atherosclerosis	0.0197	0.0527	CbGbCtD
Quetiapine—CYP3A5—Pravastatin—atherosclerosis	0.0193	0.0516	CbGbCtD
Quetiapine—CYP3A5—Lovastatin—atherosclerosis	0.0193	0.0516	CbGbCtD
Quetiapine—CYP2C19—Rosuvastatin—atherosclerosis	0.0171	0.0457	CbGbCtD
Quetiapine—CYP2C19—Simvastatin—atherosclerosis	0.0159	0.0425	CbGbCtD
Quetiapine—CYP2C19—Lovastatin—atherosclerosis	0.0156	0.0416	CbGbCtD
Quetiapine—CYP2D6—Niacin—atherosclerosis	0.0153	0.0409	CbGbCtD
Quetiapine—ABCB1—Ezetimibe—atherosclerosis	0.0138	0.0369	CbGbCtD
Quetiapine—ABCB1—Simvastatin—atherosclerosis	0.0128	0.0343	CbGbCtD
Quetiapine—ABCB1—Pravastatin—atherosclerosis	0.0126	0.0336	CbGbCtD
Quetiapine—ABCB1—Lovastatin—atherosclerosis	0.0126	0.0336	CbGbCtD
Quetiapine—CYP2D6—Simvastatin—atherosclerosis	0.0121	0.0323	CbGbCtD
Quetiapine—CYP2D6—Lovastatin—atherosclerosis	0.0118	0.0316	CbGbCtD
Quetiapine—CYP2D6—Pravastatin—atherosclerosis	0.0118	0.0316	CbGbCtD
Quetiapine—CYP3A4—Ezetimibe—atherosclerosis	0.00827	0.0221	CbGbCtD
Quetiapine—CYP3A4—Rosuvastatin—atherosclerosis	0.00827	0.0221	CbGbCtD
Quetiapine—CYP3A4—Simvastatin—atherosclerosis	0.00769	0.0205	CbGbCtD
Quetiapine—CYP3A4—Pravastatin—atherosclerosis	0.00752	0.0201	CbGbCtD
Quetiapine—CYP3A4—Lovastatin—atherosclerosis	0.00752	0.0201	CbGbCtD
Quetiapine—HTR2A—arteriole—atherosclerosis	0.00207	0.0899	CbGeAlD
Quetiapine—HTR7—vein—atherosclerosis	0.00198	0.086	CbGeAlD
Quetiapine—HTR2A—vein—atherosclerosis	0.00124	0.0536	CbGeAlD
Quetiapine—HTR1B—artery—atherosclerosis	0.00105	0.0454	CbGeAlD
Quetiapine—HTR1D—artery—atherosclerosis	0.00101	0.044	CbGeAlD
Quetiapine—HTR2A—hindlimb—atherosclerosis	0.000821	0.0356	CbGeAlD
Quetiapine—HTR1B—blood vessel—atherosclerosis	0.000816	0.0354	CbGeAlD
Quetiapine—HTR7—artery—atherosclerosis	0.000807	0.035	CbGeAlD
Quetiapine—HTR1D—blood vessel—atherosclerosis	0.00079	0.0342	CbGeAlD
Quetiapine—HTR2A—appendage—atherosclerosis	0.000705	0.0306	CbGeAlD
Quetiapine—HTR7—endothelium—atherosclerosis	0.000682	0.0296	CbGeAlD
Quetiapine—Cetirizine—HRH1—atherosclerosis	0.000664	0.141	CrCbGaD
Quetiapine—HTR7—blood vessel—atherosclerosis	0.000629	0.0273	CbGeAlD
Quetiapine—Methdilazine—HRH1—atherosclerosis	0.000532	0.113	CrCbGaD
Quetiapine—H1F0—connective tissue—atherosclerosis	0.000523	0.0227	CbGeAlD
Quetiapine—Hydroxyzine—HRH1—atherosclerosis	0.000512	0.109	CrCbGaD
Quetiapine—HTR2A—artery—atherosclerosis	0.000503	0.0218	CbGeAlD
Quetiapine—H1F0—cardiovascular system—atherosclerosis	0.000455	0.0197	CbGeAlD
Quetiapine—HTR2A—endothelium—atherosclerosis	0.000425	0.0184	CbGeAlD
Quetiapine—HTR1D—connective tissue—atherosclerosis	0.000405	0.0176	CbGeAlD
Quetiapine—H1F0—adipose tissue—atherosclerosis	0.000401	0.0174	CbGeAlD
Quetiapine—HTR2A—blood vessel—atherosclerosis	0.000392	0.017	CbGeAlD
Quetiapine—CYP3A7—liver—atherosclerosis	0.000379	0.0164	CbGeAlD
Quetiapine—HTR1B—cardiovascular system—atherosclerosis	0.000364	0.0158	CbGeAlD
Quetiapine—CHRM2—cardiovascular system—atherosclerosis	0.000362	0.0157	CbGeAlD
Quetiapine—HTR1D—cardiovascular system—atherosclerosis	0.000352	0.0153	CbGeAlD
Quetiapine—Mequitazine—HRH1—atherosclerosis	0.000334	0.0709	CrCbGaD
Quetiapine—CHRM1—cardiovascular system—atherosclerosis	0.000329	0.0143	CbGeAlD
Quetiapine—CYP3A7-CYP3A51P—liver—atherosclerosis	0.000322	0.014	CbGeAlD
Quetiapine—HTR7—connective tissue—atherosclerosis	0.000322	0.014	CbGeAlD
Quetiapine—HTR1A—cardiovascular system—atherosclerosis	0.000294	0.0127	CbGeAlD
Quetiapine—H1F0—liver—atherosclerosis	0.000281	0.0122	CbGeAlD
Quetiapine—HTR7—cardiovascular system—atherosclerosis	0.000281	0.0122	CbGeAlD
Quetiapine—Zuclopenthixol—HRH1—atherosclerosis	0.000276	0.0585	CrCbGaD
Quetiapine—ADRA1A—cardiovascular system—atherosclerosis	0.000271	0.0117	CbGeAlD
Quetiapine—Olanzapine—HRH1—atherosclerosis	0.000262	0.0557	CrCbGaD
Quetiapine—CHRM3—adipose tissue—atherosclerosis	0.00026	0.0113	CbGeAlD
Quetiapine—ABCB1—blood vessel—atherosclerosis	0.000257	0.0111	CbGeAlD
Quetiapine—Trazodone—HRH1—atherosclerosis	0.000254	0.0538	CrCbGaD
Quetiapine—HRH1—connective tissue—atherosclerosis	0.000241	0.0104	CbGeAlD
Quetiapine—ADRA1A—adipose tissue—atherosclerosis	0.000239	0.0104	CbGeAlD
Quetiapine—Thiothixene—HRH1—atherosclerosis	0.000238	0.0504	CrCbGaD
Quetiapine—ADRA2A—connective tissue—atherosclerosis	0.000236	0.0103	CbGeAlD
Quetiapine—ADRA2C—adipose tissue—atherosclerosis	0.000227	0.00986	CbGeAlD
Quetiapine—Prochlorperazine—HRH1—atherosclerosis	0.000227	0.0482	CrCbGaD
Quetiapine—Tremor—Lovastatin—atherosclerosis	0.000212	0.00147	CcSEcCtD
Quetiapine—Visual impairment—Pravastatin—atherosclerosis	0.000211	0.00147	CcSEcCtD
Quetiapine—Ill-defined disorder—Lovastatin—atherosclerosis	0.00021	0.00145	CcSEcCtD
Quetiapine—Amoxapine—HRH1—atherosclerosis	0.000209	0.0443	CrCbGaD
Quetiapine—Eye disorder—Niacin—atherosclerosis	0.000208	0.00144	CcSEcCtD
Quetiapine—Flatulence—Simvastatin—atherosclerosis	0.000208	0.00144	CcSEcCtD
Quetiapine—Tinnitus—Niacin—atherosclerosis	0.000208	0.00144	CcSEcCtD
Quetiapine—Erythema multiforme—Pravastatin—atherosclerosis	0.000207	0.00144	CcSEcCtD
Quetiapine—Dysgeusia—Simvastatin—atherosclerosis	0.000207	0.00144	CcSEcCtD
Quetiapine—Angioedema—Lovastatin—atherosclerosis	0.000206	0.00143	CcSEcCtD
Quetiapine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000205	0.00143	CcSEcCtD
Quetiapine—Fluphenazine—HRH1—atherosclerosis	0.000205	0.0436	CrCbGaD
Quetiapine—Anaemia—Ezetimibe—atherosclerosis	0.000205	0.00142	CcSEcCtD
Quetiapine—Tinnitus—Pravastatin—atherosclerosis	0.000205	0.00142	CcSEcCtD
Quetiapine—Malaise—Lovastatin—atherosclerosis	0.000204	0.00141	CcSEcCtD
Quetiapine—Cardiac disorder—Pravastatin—atherosclerosis	0.000204	0.00141	CcSEcCtD
Quetiapine—Muscle spasms—Simvastatin—atherosclerosis	0.000203	0.00141	CcSEcCtD
Quetiapine—Vertigo—Lovastatin—atherosclerosis	0.000203	0.00141	CcSEcCtD
Quetiapine—Angioedema—Ezetimibe—atherosclerosis	0.000202	0.0014	CcSEcCtD
Quetiapine—Angiopathy—Niacin—atherosclerosis	0.000202	0.0014	CcSEcCtD
Quetiapine—Leukopenia—Lovastatin—atherosclerosis	0.000202	0.0014	CcSEcCtD
Quetiapine—HTR2A—connective tissue—atherosclerosis	0.000201	0.00872	CbGeAlD
Quetiapine—Chills—Niacin—atherosclerosis	0.0002	0.00139	CcSEcCtD
Quetiapine—Malaise—Ezetimibe—atherosclerosis	0.0002	0.00139	CcSEcCtD
Quetiapine—Vision blurred—Simvastatin—atherosclerosis	0.000199	0.00138	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000198	0.00137	CcSEcCtD
Quetiapine—Tremor—Simvastatin—atherosclerosis	0.000198	0.00137	CcSEcCtD
Quetiapine—Chills—Pravastatin—atherosclerosis	0.000197	0.00137	CcSEcCtD
Quetiapine—Insomnia—Rosuvastatin—atherosclerosis	0.000197	0.00136	CcSEcCtD
Quetiapine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000196	0.00136	CcSEcCtD
Quetiapine—Palpitations—Ezetimibe—atherosclerosis	0.000196	0.00136	CcSEcCtD
Quetiapine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000195	0.00135	CcSEcCtD
Quetiapine—Anaemia—Simvastatin—atherosclerosis	0.000195	0.00135	CcSEcCtD
Quetiapine—Malnutrition—Niacin—atherosclerosis	0.000194	0.00135	CcSEcCtD
Quetiapine—Cough—Ezetimibe—atherosclerosis	0.000193	0.00134	CcSEcCtD
Quetiapine—Angioedema—Simvastatin—atherosclerosis	0.000193	0.00134	CcSEcCtD
Quetiapine—Myalgia—Lovastatin—atherosclerosis	0.000192	0.00133	CcSEcCtD
Quetiapine—Arthralgia—Lovastatin—atherosclerosis	0.000192	0.00133	CcSEcCtD
Quetiapine—Chest pain—Lovastatin—atherosclerosis	0.000192	0.00133	CcSEcCtD
Quetiapine—Anxiety—Lovastatin—atherosclerosis	0.000192	0.00133	CcSEcCtD
Quetiapine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000191	0.00133	CcSEcCtD
Quetiapine—Hypertension—Ezetimibe—atherosclerosis	0.000191	0.00133	CcSEcCtD
Quetiapine—Flatulence—Niacin—atherosclerosis	0.000191	0.00133	CcSEcCtD
Quetiapine—Malaise—Simvastatin—atherosclerosis	0.00019	0.00132	CcSEcCtD
Quetiapine—CYP3A5—adipose tissue—atherosclerosis	0.00019	0.00826	CbGeAlD
Quetiapine—Tension—Niacin—atherosclerosis	0.00019	0.00132	CcSEcCtD
Quetiapine—Discomfort—Lovastatin—atherosclerosis	0.00019	0.00132	CcSEcCtD
Quetiapine—Vertigo—Simvastatin—atherosclerosis	0.00019	0.00132	CcSEcCtD
Quetiapine—Leukopenia—Simvastatin—atherosclerosis	0.000189	0.00131	CcSEcCtD
Quetiapine—Myalgia—Ezetimibe—atherosclerosis	0.000189	0.00131	CcSEcCtD
Quetiapine—Arthralgia—Ezetimibe—atherosclerosis	0.000189	0.00131	CcSEcCtD
Quetiapine—Chest pain—Ezetimibe—atherosclerosis	0.000189	0.00131	CcSEcCtD
Quetiapine—Nervousness—Niacin—atherosclerosis	0.000188	0.00131	CcSEcCtD
Quetiapine—Flatulence—Pravastatin—atherosclerosis	0.000188	0.00131	CcSEcCtD
Quetiapine—Dry mouth—Lovastatin—atherosclerosis	0.000188	0.0013	CcSEcCtD
Quetiapine—Tension—Pravastatin—atherosclerosis	0.000187	0.0013	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000187	0.0013	CcSEcCtD
Quetiapine—Dysgeusia—Pravastatin—atherosclerosis	0.000187	0.0013	CcSEcCtD
Quetiapine—Muscle spasms—Niacin—atherosclerosis	0.000186	0.00129	CcSEcCtD
Quetiapine—Discomfort—Ezetimibe—atherosclerosis	0.000186	0.00129	CcSEcCtD
Quetiapine—Constipation—Rosuvastatin—atherosclerosis	0.000186	0.00129	CcSEcCtD
Quetiapine—Pain—Rosuvastatin—atherosclerosis	0.000186	0.00129	CcSEcCtD
Quetiapine—Confusional state—Lovastatin—atherosclerosis	0.000186	0.00129	CcSEcCtD
Quetiapine—Nervousness—Pravastatin—atherosclerosis	0.000185	0.00129	CcSEcCtD
Quetiapine—HRH1—adipose tissue—atherosclerosis	0.000185	0.00801	CbGeAlD
Quetiapine—Dry mouth—Ezetimibe—atherosclerosis	0.000184	0.00128	CcSEcCtD
Quetiapine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000184	0.00128	CcSEcCtD
Quetiapine—Muscle spasms—Pravastatin—atherosclerosis	0.000184	0.00127	CcSEcCtD
Quetiapine—Infection—Lovastatin—atherosclerosis	0.000183	0.00127	CcSEcCtD
Quetiapine—Vision blurred—Niacin—atherosclerosis	0.000183	0.00127	CcSEcCtD
Quetiapine—Confusional state—Ezetimibe—atherosclerosis	0.000182	0.00126	CcSEcCtD
Quetiapine—ADRA2A—adipose tissue—atherosclerosis	0.000181	0.00787	CbGeAlD
Quetiapine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000181	0.00125	CcSEcCtD
Quetiapine—Thrombocytopenia—Lovastatin—atherosclerosis	0.00018	0.00125	CcSEcCtD
Quetiapine—Vision blurred—Pravastatin—atherosclerosis	0.00018	0.00125	CcSEcCtD
Quetiapine—Chest pain—Simvastatin—atherosclerosis	0.00018	0.00125	CcSEcCtD
Quetiapine—Myalgia—Simvastatin—atherosclerosis	0.00018	0.00125	CcSEcCtD
Quetiapine—Arthralgia—Simvastatin—atherosclerosis	0.00018	0.00125	CcSEcCtD
Quetiapine—Infection—Ezetimibe—atherosclerosis	0.00018	0.00125	CcSEcCtD
Quetiapine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000179	0.00124	CcSEcCtD
Quetiapine—Anxiety—Simvastatin—atherosclerosis	0.000179	0.00124	CcSEcCtD
Quetiapine—Tremor—Pravastatin—atherosclerosis	0.000179	0.00124	CcSEcCtD
Quetiapine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000178	0.00123	CcSEcCtD
Quetiapine—Discomfort—Simvastatin—atherosclerosis	0.000178	0.00123	CcSEcCtD
Quetiapine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000177	0.00123	CcSEcCtD
Quetiapine—Angioedema—Niacin—atherosclerosis	0.000177	0.00123	CcSEcCtD
Quetiapine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000177	0.00123	CcSEcCtD
Quetiapine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000177	0.00123	CcSEcCtD
Quetiapine—Anaemia—Pravastatin—atherosclerosis	0.000176	0.00122	CcSEcCtD
Quetiapine—Anorexia—Lovastatin—atherosclerosis	0.000176	0.00122	CcSEcCtD
Quetiapine—Skin disorder—Ezetimibe—atherosclerosis	0.000176	0.00122	CcSEcCtD
Quetiapine—HTR2A—cardiovascular system—atherosclerosis	0.000175	0.00759	CbGeAlD
Quetiapine—Angioedema—Pravastatin—atherosclerosis	0.000174	0.00121	CcSEcCtD
Quetiapine—Vertigo—Niacin—atherosclerosis	0.000174	0.00121	CcSEcCtD
Quetiapine—Syncope—Niacin—atherosclerosis	0.000174	0.00121	CcSEcCtD
Quetiapine—Confusional state—Simvastatin—atherosclerosis	0.000174	0.00121	CcSEcCtD
Quetiapine—Leukopenia—Niacin—atherosclerosis	0.000174	0.0012	CcSEcCtD
Quetiapine—HTR7—liver—atherosclerosis	0.000174	0.00753	CbGeAlD
Quetiapine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000172	0.0012	CcSEcCtD
Quetiapine—Malaise—Pravastatin—atherosclerosis	0.000172	0.00119	CcSEcCtD
Quetiapine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000172	0.00119	CcSEcCtD
Quetiapine—Vertigo—Pravastatin—atherosclerosis	0.000172	0.00119	CcSEcCtD
Quetiapine—Palpitations—Niacin—atherosclerosis	0.000171	0.00119	CcSEcCtD
Quetiapine—Infection—Simvastatin—atherosclerosis	0.000171	0.00119	CcSEcCtD
Quetiapine—Leukopenia—Pravastatin—atherosclerosis	0.000171	0.00119	CcSEcCtD
Quetiapine—Loss of consciousness—Niacin—atherosclerosis	0.00017	0.00118	CcSEcCtD
Quetiapine—CYP2C19—liver—atherosclerosis	0.000169	0.00735	CbGeAlD
Quetiapine—Cough—Niacin—atherosclerosis	0.000169	0.00117	CcSEcCtD
Quetiapine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000169	0.00117	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000168	0.00116	CcSEcCtD
Quetiapine—ADRA1A—liver—atherosclerosis	0.000167	0.00726	CbGeAlD
Quetiapine—Insomnia—Lovastatin—atherosclerosis	0.000167	0.00116	CcSEcCtD
Quetiapine—Cough—Pravastatin—atherosclerosis	0.000167	0.00116	CcSEcCtD
Quetiapine—Paraesthesia—Lovastatin—atherosclerosis	0.000165	0.00115	CcSEcCtD
Quetiapine—Myalgia—Niacin—atherosclerosis	0.000165	0.00115	CcSEcCtD
Quetiapine—Arthralgia—Niacin—atherosclerosis	0.000165	0.00115	CcSEcCtD
Quetiapine—Hypertension—Pravastatin—atherosclerosis	0.000165	0.00114	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000165	0.00114	CcSEcCtD
Quetiapine—Anorexia—Simvastatin—atherosclerosis	0.000164	0.00114	CcSEcCtD
Quetiapine—Dyspnoea—Lovastatin—atherosclerosis	0.000164	0.00114	CcSEcCtD
Quetiapine—Trifluoperazine—HRH1—atherosclerosis	0.000164	0.0349	CrCbGaD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000164	0.00114	CcSEcCtD
Quetiapine—Insomnia—Ezetimibe—atherosclerosis	0.000163	0.00113	CcSEcCtD
Quetiapine—Loxapine—HRH1—atherosclerosis	0.000163	0.0346	CrCbGaD
Quetiapine—Arthralgia—Pravastatin—atherosclerosis	0.000163	0.00113	CcSEcCtD
Quetiapine—Myalgia—Pravastatin—atherosclerosis	0.000163	0.00113	CcSEcCtD
Quetiapine—Chest pain—Pravastatin—atherosclerosis	0.000163	0.00113	CcSEcCtD
Quetiapine—Perphenazine—HRH1—atherosclerosis	0.000162	0.0345	CrCbGaD
Quetiapine—Paraesthesia—Ezetimibe—atherosclerosis	0.000162	0.00113	CcSEcCtD
Quetiapine—Dyspepsia—Lovastatin—atherosclerosis	0.000162	0.00113	CcSEcCtD
Quetiapine—Anxiety—Pravastatin—atherosclerosis	0.000162	0.00112	CcSEcCtD
Quetiapine—Dry mouth—Niacin—atherosclerosis	0.000161	0.00112	CcSEcCtD
Quetiapine—Dyspnoea—Ezetimibe—atherosclerosis	0.000161	0.00112	CcSEcCtD
Quetiapine—Discomfort—Pravastatin—atherosclerosis	0.000161	0.00111	CcSEcCtD
Quetiapine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00016	0.00111	CcSEcCtD
Quetiapine—Decreased appetite—Lovastatin—atherosclerosis	0.00016	0.00111	CcSEcCtD
Quetiapine—ADRA2C—liver—atherosclerosis	0.000159	0.00692	CbGeAlD
Quetiapine—Dyspepsia—Ezetimibe—atherosclerosis	0.000159	0.0011	CcSEcCtD
Quetiapine—Fatigue—Lovastatin—atherosclerosis	0.000159	0.0011	CcSEcCtD
Quetiapine—Anaphylactic shock—Niacin—atherosclerosis	0.000158	0.0011	CcSEcCtD
Quetiapine—Pain—Lovastatin—atherosclerosis	0.000158	0.00109	CcSEcCtD
Quetiapine—Constipation—Lovastatin—atherosclerosis	0.000158	0.00109	CcSEcCtD
Quetiapine—Confusional state—Pravastatin—atherosclerosis	0.000157	0.00109	CcSEcCtD
Quetiapine—Decreased appetite—Ezetimibe—atherosclerosis	0.000157	0.00109	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000157	0.00109	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000156	0.00108	CcSEcCtD
Quetiapine—Asthenia—Rosuvastatin—atherosclerosis	0.000156	0.00108	CcSEcCtD
Quetiapine—Insomnia—Simvastatin—atherosclerosis	0.000156	0.00108	CcSEcCtD
Quetiapine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000156	0.00108	CcSEcCtD
Quetiapine—Fatigue—Ezetimibe—atherosclerosis	0.000156	0.00108	CcSEcCtD
Quetiapine—Shock—Niacin—atherosclerosis	0.000156	0.00108	CcSEcCtD
Quetiapine—Infection—Pravastatin—atherosclerosis	0.000155	0.00107	CcSEcCtD
Quetiapine—Paraesthesia—Simvastatin—atherosclerosis	0.000155	0.00107	CcSEcCtD
Quetiapine—Pain—Ezetimibe—atherosclerosis	0.000155	0.00107	CcSEcCtD
Quetiapine—Constipation—Ezetimibe—atherosclerosis	0.000155	0.00107	CcSEcCtD
Quetiapine—Tachycardia—Niacin—atherosclerosis	0.000154	0.00107	CcSEcCtD
Quetiapine—Pruritus—Rosuvastatin—atherosclerosis	0.000154	0.00107	CcSEcCtD
Quetiapine—Skin disorder—Niacin—atherosclerosis	0.000154	0.00107	CcSEcCtD
Quetiapine—Dyspnoea—Simvastatin—atherosclerosis	0.000154	0.00107	CcSEcCtD
Quetiapine—Hyperhidrosis—Niacin—atherosclerosis	0.000153	0.00106	CcSEcCtD
Quetiapine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000153	0.00106	CcSEcCtD
Quetiapine—Feeling abnormal—Lovastatin—atherosclerosis	0.000152	0.00105	CcSEcCtD
Quetiapine—Dyspepsia—Simvastatin—atherosclerosis	0.000152	0.00105	CcSEcCtD
Quetiapine—Anorexia—Niacin—atherosclerosis	0.000151	0.00105	CcSEcCtD
Quetiapine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000151	0.00105	CcSEcCtD
Quetiapine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000151	0.00105	CcSEcCtD
Quetiapine—Decreased appetite—Simvastatin—atherosclerosis	0.00015	0.00104	CcSEcCtD
Quetiapine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000149	0.00103	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000149	0.00103	CcSEcCtD
Quetiapine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000149	0.00103	CcSEcCtD
Quetiapine—Fatigue—Simvastatin—atherosclerosis	0.000149	0.00103	CcSEcCtD
Quetiapine—Anorexia—Pravastatin—atherosclerosis	0.000149	0.00103	CcSEcCtD
Quetiapine—Hypotension—Niacin—atherosclerosis	0.000148	0.00103	CcSEcCtD
Quetiapine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000148	0.00103	CcSEcCtD
Quetiapine—Constipation—Simvastatin—atherosclerosis	0.000147	0.00102	CcSEcCtD
Quetiapine—Pain—Simvastatin—atherosclerosis	0.000147	0.00102	CcSEcCtD
Quetiapine—Promazine—HRH1—atherosclerosis	0.000146	0.0311	CrCbGaD
Quetiapine—Body temperature increased—Lovastatin—atherosclerosis	0.000146	0.00101	CcSEcCtD
Quetiapine—Abdominal pain—Lovastatin—atherosclerosis	0.000146	0.00101	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000144	0.001	CcSEcCtD
Quetiapine—Dizziness—Rosuvastatin—atherosclerosis	0.000144	0.000998	CcSEcCtD
Quetiapine—Insomnia—Niacin—atherosclerosis	0.000143	0.000993	CcSEcCtD
Quetiapine—Abdominal pain—Ezetimibe—atherosclerosis	0.000143	0.000991	CcSEcCtD
Quetiapine—Body temperature increased—Ezetimibe—atherosclerosis	0.000143	0.000991	CcSEcCtD
Quetiapine—Paraesthesia—Niacin—atherosclerosis	0.000142	0.000986	CcSEcCtD
Quetiapine—Feeling abnormal—Simvastatin—atherosclerosis	0.000142	0.000986	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000142	0.000985	CcSEcCtD
Quetiapine—Dyspnoea—Niacin—atherosclerosis	0.000141	0.000979	CcSEcCtD
Quetiapine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000141	0.000978	CcSEcCtD
Quetiapine—Insomnia—Pravastatin—atherosclerosis	0.000141	0.000978	CcSEcCtD
Quetiapine—Somnolence—Niacin—atherosclerosis	0.000141	0.000976	CcSEcCtD
Quetiapine—Paraesthesia—Pravastatin—atherosclerosis	0.00014	0.000971	CcSEcCtD
Quetiapine—Dyspepsia—Niacin—atherosclerosis	0.000139	0.000967	CcSEcCtD
Quetiapine—Dyspnoea—Pravastatin—atherosclerosis	0.000139	0.000964	CcSEcCtD
Quetiapine—Decreased appetite—Niacin—atherosclerosis	0.000138	0.000955	CcSEcCtD
Quetiapine—Dyspepsia—Pravastatin—atherosclerosis	0.000137	0.000952	CcSEcCtD
Quetiapine—Rash—Rosuvastatin—atherosclerosis	0.000137	0.000951	CcSEcCtD
Quetiapine—Dermatitis—Rosuvastatin—atherosclerosis	0.000137	0.00095	CcSEcCtD
Quetiapine—Clozapine—HRH1—atherosclerosis	0.000137	0.0291	CrCbGaD
Quetiapine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000137	0.000948	CcSEcCtD
Quetiapine—Abdominal pain—Simvastatin—atherosclerosis	0.000136	0.000945	CcSEcCtD
Quetiapine—Body temperature increased—Simvastatin—atherosclerosis	0.000136	0.000945	CcSEcCtD
Quetiapine—Headache—Rosuvastatin—atherosclerosis	0.000136	0.000945	CcSEcCtD
Quetiapine—Hypersensitivity—Lovastatin—atherosclerosis	0.000136	0.000942	CcSEcCtD
Quetiapine—Decreased appetite—Pravastatin—atherosclerosis	0.000135	0.00094	CcSEcCtD
Quetiapine—Pain—Niacin—atherosclerosis	0.000135	0.000939	CcSEcCtD
Quetiapine—Fatigue—Pravastatin—atherosclerosis	0.000134	0.000932	CcSEcCtD
Quetiapine—CYP3A5—liver—atherosclerosis	0.000133	0.00579	CbGeAlD
Quetiapine—Pain—Pravastatin—atherosclerosis	0.000133	0.000925	CcSEcCtD
Quetiapine—Constipation—Pravastatin—atherosclerosis	0.000133	0.000925	CcSEcCtD
Quetiapine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000133	0.000924	CcSEcCtD
Quetiapine—Asthenia—Lovastatin—atherosclerosis	0.000132	0.000917	CcSEcCtD
Quetiapine—Pruritus—Lovastatin—atherosclerosis	0.00013	0.000905	CcSEcCtD
Quetiapine—Asthenia—Ezetimibe—atherosclerosis	0.00013	0.0009	CcSEcCtD
Quetiapine—Gastrointestinal pain—Niacin—atherosclerosis	0.000129	0.000898	CcSEcCtD
Quetiapine—Nausea—Rosuvastatin—atherosclerosis	0.000129	0.000896	CcSEcCtD
Quetiapine—Feeling abnormal—Pravastatin—atherosclerosis	0.000128	0.000891	CcSEcCtD
Quetiapine—Pruritus—Ezetimibe—atherosclerosis	0.000128	0.000887	CcSEcCtD
Quetiapine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000127	0.000884	CcSEcCtD
Quetiapine—Hypersensitivity—Simvastatin—atherosclerosis	0.000127	0.000881	CcSEcCtD
Quetiapine—Diarrhoea—Lovastatin—atherosclerosis	0.000126	0.000875	CcSEcCtD
Quetiapine—Abdominal pain—Niacin—atherosclerosis	0.000125	0.000868	CcSEcCtD
Quetiapine—Body temperature increased—Niacin—atherosclerosis	0.000125	0.000868	CcSEcCtD
Quetiapine—Asthenia—Simvastatin—atherosclerosis	0.000124	0.000858	CcSEcCtD
Quetiapine—Diarrhoea—Ezetimibe—atherosclerosis	0.000124	0.000858	CcSEcCtD
Quetiapine—Abdominal pain—Pravastatin—atherosclerosis	0.000123	0.000855	CcSEcCtD
Quetiapine—Body temperature increased—Pravastatin—atherosclerosis	0.000123	0.000855	CcSEcCtD
Quetiapine—Pruritus—Simvastatin—atherosclerosis	0.000122	0.000846	CcSEcCtD
Quetiapine—Dizziness—Lovastatin—atherosclerosis	0.000122	0.000846	CcSEcCtD
Quetiapine—Dizziness—Ezetimibe—atherosclerosis	0.00012	0.000829	CcSEcCtD
Quetiapine—Diarrhoea—Simvastatin—atherosclerosis	0.000118	0.000818	CcSEcCtD
Quetiapine—Vomiting—Lovastatin—atherosclerosis	0.000117	0.000813	CcSEcCtD
Quetiapine—Hypersensitivity—Niacin—atherosclerosis	0.000117	0.000809	CcSEcCtD
Quetiapine—Rash—Lovastatin—atherosclerosis	0.000116	0.000806	CcSEcCtD
Quetiapine—Dermatitis—Lovastatin—atherosclerosis	0.000116	0.000805	CcSEcCtD
Quetiapine—Headache—Lovastatin—atherosclerosis	0.000115	0.000801	CcSEcCtD
Quetiapine—Vomiting—Ezetimibe—atherosclerosis	0.000115	0.000797	CcSEcCtD
Quetiapine—Hypersensitivity—Pravastatin—atherosclerosis	0.000115	0.000797	CcSEcCtD
Quetiapine—ABCB1—cardiovascular system—atherosclerosis	0.000115	0.00497	CbGeAlD
Quetiapine—Dizziness—Simvastatin—atherosclerosis	0.000114	0.000791	CcSEcCtD
Quetiapine—Rash—Ezetimibe—atherosclerosis	0.000114	0.000791	CcSEcCtD
Quetiapine—Dermatitis—Ezetimibe—atherosclerosis	0.000114	0.00079	CcSEcCtD
Quetiapine—Asthenia—Niacin—atherosclerosis	0.000114	0.000788	CcSEcCtD
Quetiapine—Headache—Ezetimibe—atherosclerosis	0.000113	0.000786	CcSEcCtD
Quetiapine—Pruritus—Niacin—atherosclerosis	0.000112	0.000777	CcSEcCtD
Quetiapine—Asthenia—Pravastatin—atherosclerosis	0.000112	0.000776	CcSEcCtD
Quetiapine—Pruritus—Pravastatin—atherosclerosis	0.00011	0.000765	CcSEcCtD
Quetiapine—Vomiting—Simvastatin—atherosclerosis	0.00011	0.00076	CcSEcCtD
Quetiapine—Nausea—Lovastatin—atherosclerosis	0.000109	0.00076	CcSEcCtD
Quetiapine—Rash—Simvastatin—atherosclerosis	0.000109	0.000754	CcSEcCtD
Quetiapine—Dermatitis—Simvastatin—atherosclerosis	0.000109	0.000753	CcSEcCtD
Quetiapine—Diarrhoea—Niacin—atherosclerosis	0.000108	0.000751	CcSEcCtD
Quetiapine—HTR2A—liver—atherosclerosis	0.000108	0.00469	CbGeAlD
Quetiapine—Headache—Simvastatin—atherosclerosis	0.000108	0.000749	CcSEcCtD
Quetiapine—Nausea—Ezetimibe—atherosclerosis	0.000107	0.000745	CcSEcCtD
Quetiapine—Diarrhoea—Pravastatin—atherosclerosis	0.000107	0.00074	CcSEcCtD
Quetiapine—Dizziness—Niacin—atherosclerosis	0.000105	0.000726	CcSEcCtD
Quetiapine—Dizziness—Pravastatin—atherosclerosis	0.000103	0.000715	CcSEcCtD
Quetiapine—Nausea—Simvastatin—atherosclerosis	0.000102	0.00071	CcSEcCtD
Quetiapine—ABCB1—adipose tissue—atherosclerosis	0.000101	0.00439	CbGeAlD
Quetiapine—Vomiting—Niacin—atherosclerosis	0.000101	0.000698	CcSEcCtD
Quetiapine—CYP3A4—liver—atherosclerosis	0.0001	0.00434	CbGeAlD
Quetiapine—Rash—Niacin—atherosclerosis	9.98e-05	0.000692	CcSEcCtD
Quetiapine—Dermatitis—Niacin—atherosclerosis	9.97e-05	0.000692	CcSEcCtD
Quetiapine—Headache—Niacin—atherosclerosis	9.92e-05	0.000688	CcSEcCtD
Quetiapine—Vomiting—Pravastatin—atherosclerosis	9.91e-05	0.000688	CcSEcCtD
Quetiapine—CYP2D6—liver—atherosclerosis	9.86e-05	0.00428	CbGeAlD
Quetiapine—Rash—Pravastatin—atherosclerosis	9.83e-05	0.000682	CcSEcCtD
Quetiapine—Dermatitis—Pravastatin—atherosclerosis	9.82e-05	0.000681	CcSEcCtD
Quetiapine—Headache—Pravastatin—atherosclerosis	9.76e-05	0.000677	CcSEcCtD
Quetiapine—Nausea—Niacin—atherosclerosis	9.4e-05	0.000652	CcSEcCtD
Quetiapine—Nausea—Pravastatin—atherosclerosis	9.26e-05	0.000642	CcSEcCtD
Quetiapine—ABCB1—liver—atherosclerosis	7.09e-05	0.00308	CbGeAlD
Quetiapine—Olanzapine—ALB—atherosclerosis	6.06e-05	0.0129	CrCbGaD
Quetiapine—Thioproperazine—ALB—atherosclerosis	5.58e-05	0.0118	CrCbGaD
Quetiapine—Thiothixene—ALB—atherosclerosis	5.49e-05	0.0116	CrCbGaD
Quetiapine—Pipotiazine—ALB—atherosclerosis	5.49e-05	0.0116	CrCbGaD
Quetiapine—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	2.19e-06	2.06e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—IL6—atherosclerosis	2.18e-06	2.05e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—TGFB1—atherosclerosis	2.18e-06	2.05e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—IL6—atherosclerosis	2.17e-06	2.04e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—VEGFA—atherosclerosis	2.17e-06	2.04e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—AGT—atherosclerosis	2.16e-06	2.03e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—MAPK3—atherosclerosis	2.15e-06	2.03e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MMP9—atherosclerosis	2.15e-06	2.02e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—STAT3—atherosclerosis	2.15e-06	2.02e-05	CbGpPWpGaD
Quetiapine—ADRA2C—GPCR downstream signaling—AKT1—atherosclerosis	2.15e-06	2.02e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—VEGFA—atherosclerosis	2.14e-06	2.01e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—VEGFA—atherosclerosis	2.14e-06	2.01e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	2.13e-06	2e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—NFKB1—atherosclerosis	2.13e-06	2e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—STAT3—atherosclerosis	2.12e-06	1.99e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—STAT3—atherosclerosis	2.12e-06	1.99e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—APOE—atherosclerosis	2.12e-06	1.99e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—IL6—atherosclerosis	2.11e-06	1.99e-05	CbGpPWpGaD
Quetiapine—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	2.11e-06	1.99e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.1e-06	1.98e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—CAV1—atherosclerosis	2.1e-06	1.97e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MAPK8—atherosclerosis	2.09e-06	1.97e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—APOA1—atherosclerosis	2.09e-06	1.97e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TGFB1—atherosclerosis	2.09e-06	1.96e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—AKT1—atherosclerosis	2.09e-06	1.96e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—AKT1—atherosclerosis	2.08e-06	1.96e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	2.08e-06	1.96e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MMP9—atherosclerosis	2.08e-06	1.95e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	2.08e-06	1.95e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MMP9—atherosclerosis	2.07e-06	1.94e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	2.05e-06	1.93e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—MAPK3—atherosclerosis	2.05e-06	1.93e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	2.04e-06	1.92e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PTGS2—atherosclerosis	2.04e-06	1.92e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	2.03e-06	1.91e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CG—atherosclerosis	2.03e-06	1.91e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—MAPK3—atherosclerosis	2.02e-06	1.9e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—MAPK3—atherosclerosis	2.02e-06	1.9e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	2.02e-06	1.9e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CXCL8—atherosclerosis	2.02e-06	1.9e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	2.01e-06	1.89e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MMP9—atherosclerosis	2.01e-06	1.89e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	2.01e-06	1.89e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PPARG—atherosclerosis	2e-06	1.89e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	2e-06	1.88e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TGFB1—atherosclerosis	1.99e-06	1.87e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—NFKB1—atherosclerosis	1.99e-06	1.87e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	1.98e-06	1.87e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CXCL8—atherosclerosis	1.98e-06	1.86e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	1.98e-06	1.86e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	1.97e-06	1.86e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	1.97e-06	1.85e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—INS—atherosclerosis	1.97e-06	1.85e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TGFB1—atherosclerosis	1.96e-06	1.85e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TGFB1—atherosclerosis	1.96e-06	1.85e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	1.96e-06	1.84e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PPARG—atherosclerosis	1.96e-06	1.84e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MAPK8—atherosclerosis	1.95e-06	1.84e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—AKT1—atherosclerosis	1.95e-06	1.83e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	1.95e-06	1.83e-05	CbGpPWpGaD
Quetiapine—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	1.95e-06	1.83e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	1.94e-06	1.83e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	1.93e-06	1.82e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	1.92e-06	1.81e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—INS—atherosclerosis	1.92e-06	1.8e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	1.92e-06	1.8e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—IL6—atherosclerosis	1.92e-06	1.8e-05	CbGpPWpGaD
Quetiapine—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	1.92e-06	1.8e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	1.91e-06	1.8e-05	CbGpPWpGaD
Quetiapine—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	1.91e-06	1.8e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.91e-06	1.8e-05	CbGpPWpGaD
Quetiapine—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	1.91e-06	1.79e-05	CbGpPWpGaD
Quetiapine—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	1.9e-06	1.79e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—IL6—atherosclerosis	1.89e-06	1.77e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—IL6—atherosclerosis	1.88e-06	1.77e-05	CbGpPWpGaD
Quetiapine—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	1.88e-06	1.77e-05	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	1.88e-06	1.76e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—IL6—atherosclerosis	1.88e-06	1.76e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—IL6—atherosclerosis	1.87e-06	1.76e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	1.86e-06	1.75e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	1.86e-06	1.75e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—IL6—atherosclerosis	1.85e-06	1.74e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	1.85e-06	1.74e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—STAT3—atherosclerosis	1.85e-06	1.74e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PPARG—atherosclerosis	1.84e-06	1.73e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—STAT3—atherosclerosis	1.84e-06	1.73e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	1.83e-06	1.72e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MMP9—atherosclerosis	1.82e-06	1.72e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—INS—atherosclerosis	1.81e-06	1.7e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.8e-06	1.7e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	1.8e-06	1.7e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—VEGFA—atherosclerosis	1.8e-06	1.7e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—NFKB1—atherosclerosis	1.8e-06	1.7e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—ALB—atherosclerosis	1.8e-06	1.7e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MMP9—atherosclerosis	1.79e-06	1.69e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MMP9—atherosclerosis	1.79e-06	1.68e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—STAT3—atherosclerosis	1.79e-06	1.68e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MMP9—atherosclerosis	1.78e-06	1.68e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MMP9—atherosclerosis	1.78e-06	1.67e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	1.78e-06	1.67e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	1.77e-06	1.67e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MAPK8—atherosclerosis	1.77e-06	1.67e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	1.77e-06	1.67e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—NFKB1—atherosclerosis	1.77e-06	1.67e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—AKT1—atherosclerosis	1.77e-06	1.66e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	1.77e-06	1.66e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	1.76e-06	1.66e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MMP9—atherosclerosis	1.76e-06	1.66e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	1.76e-06	1.66e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—ALB—atherosclerosis	1.76e-06	1.65e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	1.76e-06	1.65e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	1.76e-06	1.65e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	1.75e-06	1.65e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	1.74e-06	1.64e-05	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	1.74e-06	1.64e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	1.74e-06	1.64e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—IL6—atherosclerosis	1.74e-06	1.64e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MAPK8—atherosclerosis	1.74e-06	1.64e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—IL6—atherosclerosis	1.74e-06	1.64e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	1.74e-06	1.64e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	1.74e-06	1.63e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—AKT1—atherosclerosis	1.74e-06	1.63e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	1.74e-06	1.63e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	1.73e-06	1.63e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	1.73e-06	1.63e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—IL6—atherosclerosis	1.73e-06	1.63e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—APOB—atherosclerosis	1.73e-06	1.63e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	1.73e-06	1.62e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—NOS3—atherosclerosis	1.72e-06	1.62e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	1.72e-06	1.61e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	1.71e-06	1.61e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	1.71e-06	1.61e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	1.71e-06	1.61e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	1.71e-06	1.61e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MAPK3—atherosclerosis	1.71e-06	1.61e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	1.7e-06	1.6e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	1.7e-06	1.6e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—IL6—atherosclerosis	1.69e-06	1.59e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—NOS3—atherosclerosis	1.68e-06	1.58e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.68e-06	1.58e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	1.68e-06	1.58e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—IL6—atherosclerosis	1.67e-06	1.57e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—ALB—atherosclerosis	1.66e-06	1.56e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TGFB1—atherosclerosis	1.66e-06	1.56e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—LPL—atherosclerosis	1.65e-06	1.55e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—IL6—atherosclerosis	1.64e-06	1.55e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—VEGFA—atherosclerosis	1.64e-06	1.54e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	1.63e-06	1.54e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	1.63e-06	1.53e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—STAT3—atherosclerosis	1.62e-06	1.52e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	1.61e-06	1.52e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	1.61e-06	1.52e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GPX1—atherosclerosis	1.61e-06	1.51e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—VEGFA—atherosclerosis	1.61e-06	1.51e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—AKT1—atherosclerosis	1.61e-06	1.51e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—AKT1—atherosclerosis	1.61e-06	1.51e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	1.6e-06	1.51e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	1.6e-06	1.5e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—AKT1—atherosclerosis	1.6e-06	1.5e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—STAT3—atherosclerosis	1.6e-06	1.5e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—STAT3—atherosclerosis	1.59e-06	1.5e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	1.59e-06	1.49e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—STAT3—atherosclerosis	1.59e-06	1.49e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—NOS3—atherosclerosis	1.59e-06	1.49e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	1.58e-06	1.49e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	1.58e-06	1.49e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—STAT3—atherosclerosis	1.58e-06	1.49e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	1.58e-06	1.48e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTGS2—atherosclerosis	1.58e-06	1.48e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—IL6—atherosclerosis	1.57e-06	1.48e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CD36—atherosclerosis	1.57e-06	1.48e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—STAT3—atherosclerosis	1.57e-06	1.47e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—AKT1—atherosclerosis	1.56e-06	1.47e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	1.56e-06	1.47e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MAPK3—atherosclerosis	1.55e-06	1.46e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTGS2—atherosclerosis	1.54e-06	1.45e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—AKT1—atherosclerosis	1.54e-06	1.45e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	1.52e-06	1.43e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MAPK3—atherosclerosis	1.52e-06	1.43e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—AKT1—atherosclerosis	1.52e-06	1.43e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	1.52e-06	1.43e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	1.51e-06	1.42e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TGFB1—atherosclerosis	1.5e-06	1.41e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—IL6—atherosclerosis	1.5e-06	1.41e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	1.5e-06	1.41e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	1.49e-06	1.4e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.49e-06	1.4e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—IL6—atherosclerosis	1.48e-06	1.39e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—IL6—atherosclerosis	1.48e-06	1.39e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	1.48e-06	1.39e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TGFB1—atherosclerosis	1.48e-06	1.39e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	1.47e-06	1.38e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	1.47e-06	1.38e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	1.47e-06	1.38e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PPARA—atherosclerosis	1.46e-06	1.37e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—AKT1—atherosclerosis	1.45e-06	1.37e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	1.45e-06	1.37e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	1.45e-06	1.37e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTGS2—atherosclerosis	1.45e-06	1.36e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	1.45e-06	1.36e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—AKT1—atherosclerosis	1.42e-06	1.33e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—AGT—atherosclerosis	1.41e-06	1.33e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	1.39e-06	1.3e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—AKT1—atherosclerosis	1.38e-06	1.3e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—APOE—atherosclerosis	1.38e-06	1.3e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—AKT1—atherosclerosis	1.38e-06	1.3e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CAV1—atherosclerosis	1.37e-06	1.29e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—APOA1—atherosclerosis	1.37e-06	1.29e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—AKT1—atherosclerosis	1.37e-06	1.28e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—AKT1—atherosclerosis	1.37e-06	1.28e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	1.35e-06	1.27e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—IL6—atherosclerosis	1.34e-06	1.26e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—IL6—atherosclerosis	1.29e-06	1.21e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—IL6—atherosclerosis	1.28e-06	1.21e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.25e-06	1.17e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IL6—atherosclerosis	1.25e-06	1.17e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	1.23e-06	1.16e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IL6—atherosclerosis	1.23e-06	1.16e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—AKT1—atherosclerosis	1.22e-06	1.15e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PPARG—atherosclerosis	1.21e-06	1.13e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—AKT1—atherosclerosis	1.19e-06	1.12e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—AKT1—atherosclerosis	1.18e-06	1.11e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—INS—atherosclerosis	1.18e-06	1.11e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—AKT1—atherosclerosis	1.15e-06	1.08e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	1.13e-06	1.07e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL6—atherosclerosis	1.13e-06	1.07e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—AKT1—atherosclerosis	1.12e-06	1.05e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL6—atherosclerosis	1.11e-06	1.05e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL6—atherosclerosis	1.11e-06	1.05e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL6—atherosclerosis	1.11e-06	1.04e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL6—atherosclerosis	1.1e-06	1.04e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL6—atherosclerosis	1.09e-06	1.03e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL6—atherosclerosis	1.09e-06	1.03e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ALB—atherosclerosis	1.08e-06	1.02e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—AKT1—atherosclerosis	1.04e-06	9.83e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—NOS3—atherosclerosis	1.04e-06	9.75e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—AKT1—atherosclerosis	1.03e-06	9.67e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—AKT1—atherosclerosis	1.03e-06	9.65e-06	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—AKT1—atherosclerosis	1.02e-06	9.64e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—AKT1—atherosclerosis	1.02e-06	9.62e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—AKT1—atherosclerosis	1.02e-06	9.59e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL6—atherosclerosis	1.01e-06	9.54e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—AKT1—atherosclerosis	1.01e-06	9.49e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	1.01e-06	9.47e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTGS2—atherosclerosis	9.48e-07	8.92e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	9.35e-07	8.8e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—AKT1—atherosclerosis	7.92e-07	7.45e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—AKT1—atherosclerosis	7.73e-07	7.27e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—AKT1—atherosclerosis	7.29e-07	6.86e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—AKT1—atherosclerosis	4.76e-07	4.48e-06	CbGpPWpGaD
